FDA Approved: ICATIBANT — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's original application for icatibant, a generic formulation for the treatment of acute attacks of hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ICATIBANT (icatibant)

Snippet

ORIG AP for ICATIBANT (ICATIBANT)